Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2025 - 2030
-100%
Report Coverage
Argentina

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Argentina cancer diagnostics market, 2018-2030 (US$M)

Argentina cancer diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Argentina cancer diagnostics market highlights

  • The Argentina cancer diagnostics market generated a revenue of USD 1,140.5 million in 2023 and is expected to reach USD 1,759.2 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
  • In terms of segment, consumables was the largest revenue generating product in 2023.
  • Consumables is the most lucrative product segment registering the fastest growth during the forecast period.


Cancer diagnostics market data book summary

Market revenue in 2023USD 1,140.5 million
Market revenue in 2030USD 1,759.2 million
Growth rate6.4% (CAGR from 2023 to 2030)
Largest segmentConsumables
Fastest growing segmentConsumables
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationServices, Instruments, Consumables
Key market players worldwideAbbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc


Other key industry trends

  • In terms of revenue, Argentina accounted for 1.1% of the global cancer diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 3,107.1 million by 2030.

Consumables was the largest segment with a revenue share of 59.95% in 2024. Horizon Databook has segmented the Argentina cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.


Constant developments by market players, such as geographic expansion and new product launches, have contributed to Argentina’s market growth. For instance, Amoy Diagnostics Co., Ltd. entered into a collaboration agreement with Merck KGaA to bring liquid biopsy RAS biomarker tests to Argentina, Mexico, India, and Brazil.

Initially, the test would be made available for research use, only until it gets regulatory authorization from respective countries. In addition, the country has a higher burden of cancer, which is propelling the demand for the adoption of cancer screening tests.

Moreover, Latin America has observed a steady rise in the number of oncologists, especially in Brazil and Argentina, as well as awareness of the region's long-standing scarcity of cancer specialists. A regional hub for Latin America has been established at the National Cancer Institute of Argentina (Instituto Nacional del Cáncer de Argentina) in Buenos Aires to enhance and promote activities under the initiative in the region. However, socioeconomic barriers are high in the country, along with limited healthcare facilities that can provide these tests, thus increasing the turnaround time required due to the export of samples to central laboratories in other countries.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Koninklijke Philips NV View profile 73712 Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC https://www.philips.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com

Argentina Cancer Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online